On July 18,2019, OWC received approval from the Israeli Medical Cannabis Agency to perform an efficacy study using OWC's topical ointment on psoriatic patients. (According to an SEC filing.)
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
